[{"id":"cb2c4a68-e5b0-4caa-bd52-849e62ec276a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05909241","created_at":"2023-06-18T17:07:50.063Z","updated_at":"2024-07-02T16:35:07.498Z","phase":"Phase 1","brief_title":"A Study of BA1202 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05909241","lead_sponsor":"Shandong Boan Biotechnology Co., Ltd","biomarkers":" CEACAM5","pipe":"","alterations":" ","tags":["CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BA1202"],"overall_status":"Recruiting","enrollment":" Enrollment 78","initiation":"Initiation: 08/16/2023","start_date":" 08/16/2023","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2024-04-25"}]